Stock EPRX EUPRAXIA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Eupraxia Pharmaceuticals Inc.

Equities

EPRX

CA29842P1053

Market Closed - Toronto S.E.
Other stock markets
 16:00:00 2024-05-31 EDT 		5-day change 1st Jan Change
3.65 CAD -4.20% Intraday chart for Eupraxia Pharmaceuticals Inc. -6.41% -32.03%
05-23 Eupraxia Pharmaceuticals Expanding RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis MT
05-23 Eupraxia Pharmaceuticals Inc. Brief: Announcing Expansion of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
EUPRAXIA PHARMACEUTICALS INC. Stock Eupraxia Pharmaceuticals Inc.
 99.33M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 58.06B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 40.53B
LONZA GROUP AG Stock Lonza Group AG
 38.99B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.7B
CELLTRION, INC. Stock Celltrion, Inc.
 26.56B
  1. Stock Market
  2. Equities
  3. EPRX Stock
  4. Charts Eupraxia Pharmaceuticals Inc.
  5. Sector Chart